Complete regression of a previously untreated melanoma brain metastasis with ipilimumab

被引:58
作者
Schartz, Noel E. C.
Farges, Cecile [2 ]
Madelaine, Isabelle
Bruzzoni, Heriberto [3 ]
Calvo, Fabien [3 ]
Hoos, Axel [4 ]
Lebbe, Celeste [1 ]
机构
[1] Univ Paris 07, Hop St Louis, AP HP, Skin Res Ctr,Dept Dermatol,INSERM,U976, F-75475 Paris 10, France
[2] Hop St Louis, AP HP, Dept Radiol, Paris, France
[3] Hop St Louis, AP HP, CIC Ctr Clin Invest, Paris, France
[4] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
关键词
brain metastasis; ipilimumab; melanoma; VACCINATION; BLOCKADE; RESPONSES; ANTIGEN-4; ANTIBODY;
D O I
10.1097/CMR.0b013e3283364a37
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anecdotal cases of partial or complete responses have been reported after ipilimumab therapy for stage IV melanoma with brain metastasis treated earlier by surgery or radiosurgery. We report the first case of ipilimumab monotherapy resulting in durable complete remission of untreated, progressive brain metastases in a patient with stage IV melanoma. This case and earlier reports provide support for the further evaluation of ipilimumab in melanoma patients with brain metastasis. Melanoma Res 20:247-250 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:247 / 250
页数:4
相关论文
共 21 条
  • [1] BERMAN D, 2008, J CLIN ONCOL S, V26, pS19
  • [2] CHIN K, 2008, ANN ONCOL S, V19, pS8
  • [3] Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
    Downey, Stephanie G.
    Klapper, Jacob A.
    Smith, Franz O.
    Yang, James C.
    Sherry, Richard M.
    Royal, Richard E.
    Kammula, Udai S.
    Hughes, Marybeth S.
    Allen, Tamika E.
    Levy, Catherine L.
    Yellin, Michael
    Nich, Geoffrey
    White, Donald E.
    Steinberg, Seth M.
    Rosenberg, Steven A.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (22) : 6681 - 6688
  • [4] HAMID O, 2008, J CLIN ONCOL S, V26, pS19
  • [5] CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
    Hodi, F. Stephen
    Oble, Darryl A.
    Drappatz, Jan
    Velazquez, Elsa F.
    Ramaiya, Nikhil
    Ramakrishna, Naren
    Day, Arthur L.
    Kruse, Andrea
    Mac Rae, Suzanne
    Hoos, Axel
    Mihm, Martin
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (09): : 557 - 561
  • [6] Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
    Hodi, F. Stephen
    Butler, Marcus
    Oble, Darryl A.
    Seiden, Michael V.
    Haluska, Frank G.
    Kruse, Andrea
    MacRae, Suzanne
    Nelson, Marybeth
    Canning, Christine
    Lowy, Israel
    Korman, Alan
    Lautz, David
    Russell, Sara
    Jaklitsch, Michael T.
    Ramaiya, Nikhil
    Chen, Teresa C.
    Neuberg, Donna
    Allison, James P.
    Mihm, Martin C.
    Dranoff, Glenn
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) : 3005 - 3010
  • [7] HODI FS, 2008, J CLIN ONCOL S, V26, pS19
  • [8] Checkpoint blockade in cancer immunotherapy
    Korman, AJ
    Peggs, KS
    Allison, JP
    [J]. ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY, 2006, 90 : 297 - 339
  • [9] LEBBE C, 2008, ANN ONCOL S, V19, pS8
  • [10] Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
    Liau, LM
    Prins, RM
    Kiertscher, SM
    Odesa, SK
    Kremen, TJ
    Giovannone, AJ
    Lin, JW
    Chute, DJ
    Mischel, PS
    Cloughesy, TF
    Roth, MD
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (15) : 5515 - 5525